Remove 2010 Remove Clinic Remove Hospital Remove Patients
article thumbnail

My Green Doctor Begins Pilot with Weill Cornell Medicine

My Green Doctor

With a network of over 1,300 physicians and 40+ patient care locations across New York City, Weill Cornell’s influence in healthcare delivery and education is far-reaching. The pilot, currently focused on a select practice within the system, reflects a growing interest in integrating climate-smart operations into everyday clinical care.

article thumbnail

The Rising Tide of Medical Waste: One Model for Improvement

My Green Doctor

Innovative surgeries, novel pharmaceuticals, and state of the art technology are just a few of the driving forces that have aided the delivery of exceptional care to patients across all specialties. Dilating and anesthetic eye drops are used routinely to treat patients in most ophthalmology clinics. 3 “Each U.S. 3 “Each U.S.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Green Practice News: May 2025

My Green Doctor

In This Issue : Why Renewable Energy Belongs in Every Clinic Medical Waste: One Model for Improvement OnTrack with your Sustainability Goals? Powering Health, Protecting the Planet – Why Renewable Energy Belongs in Every Clinic Healthcare professionals have always been trusted voices on public health.

article thumbnail

How Locum Tenens Fits Into Modern Healthcare Staffing Solutions

Barton Associates

There’s a lot that goes into running a healthcare facility , from managing patient care to ensuring adequate coverage around the clock. In these complex and ever-changing environments, staffing challenges can quickly become a critical issue, impacting both patient care quality and operational efficiency.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law

Regulating LDTs: A Long and Winding Road In what might sound to some like protesting too much, the PR invokes FDA’s longstanding assertion that IVDs “manufactured” by laboratories are medical devices and that clinical laboratories that develop tests are acting as manufacturers. FDA’s position is, however, only one side of the story.

article thumbnail

D.C. Circuit Sides with Manufacturers in Latest 340B Contract Pharmacy Case

FDA Law

The 340B statute requires drug manufacturers to sell certain drugs at discounted ceiling prices to covered entities, which are defined by statute to include certain types of safety net hospitals, health centers, and clinics receiving federal grants.

article thumbnail

Long Time Passing: Where Have All the De Novo Decision Summaries Gone?

FDA Law

Each of these De Novos can represent a clinical advance. Since 2010, FDA has posted classification orders and decision summaries for devices classified through the De Novo classification process. calendar years is both inexplicable and deprives patients and clinicians of options.